Research article
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
-
* Corresponding authors: Anita Langerød anita.langerod@medisin.uio.no - Stefanie S Jeffrey ssj@stanford.edu
1 Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway N-0310
2 Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
3 Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA
4 Department of Mathematics, University of Oslo, Oslo, Norway N-0316
5 Department of Pathology, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway N-0310
6 Faculty of Medicine, University of Oslo, Oslo, Norway
7 Department of Surgery, Akershus University Hospital, Nordbyhagen, Norway N-1474
8 Cancer Center, Ullevål University Hospital, Oslo, Norway N-0407
9 Department of Surgery, Ullevål University Hospital, Oslo, Norway N-0407
Breast Cancer Research 2007, 9:R30 doi:10.1186/bcr1675
Published: 15 May 2007Additional files
Additional file 1:
A table listing clinical information (array).
Format: PDF Size: 19KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 3:
A table listing TP53 associated genes.
Format: PDF Size: 312KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 2:
A table listing TP53 mutations.
Format: PDF Size: 15KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 4:
A figure showing the hierarchical clustering using the total set of genes.
Format: PDF Size: 2.2MB Download file
This file can be viewed with: Adobe Acrobat Reader